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ABSTRACt  The insulin  receptor possesses an insulin-stimulated  tyrosine-kinase activity;  how- 
ever,  the  significance  of  receptor  phosphorylation  in  terms  of  the  binding  and  signaling 
function  of  the  receptor  is  unclear.  To  help  clarify  this  problem,  we  have  studied  insulin 
binding and  receptor phosphorylation  in a Cloudman  $91  melanoma cell  line and two of its 
variants:  the  wild type  (IA)  in  which  insulin  inhibits  cell  growth,  an  insulin-resistant  variant 
(111) in which insulin  neither stimulates or inhibits growth, and a variant (46) in which insulin 
stimulates cell growth. 
t251-insulin binding  to  intact  cells  was  similar  for  the  wild-type  1A  and  insulin-stimulated 
variant  46.  The  insulin-resistant  variant  111, in  contrast,  showed  ~30%  decrease  in  insulin 
binding.  This was due to a decrease  of receptor affinity with no major difference  in receptor 
number.  When  the  melanoma  cells  were  solubilized  in  1%  Triton  X-100  and  the  insulin 
receptor was partially purified  by chromatography on wheat germ agglutinin-agarose,  a similar 
pattern of binding was observed. 
Phosphorylation  was studied  by  incubation  of the  partially  purified  receptor  with  insulin 
and  [3,-32P]ATP, and  the  receptor  was  identified  by  immunoprecipitation  and  NaDodSO4 
PAGE. Insulin  stimulated  phosphorylation  of the 95,000-mol-wt/3-subunit  of the  receptor in 
all three cells types with similar kinetics.  The amount of 32p incorporated  into the ~-subunit in 
the  insulin-resistant  cell  line  111  was ~50% of that observed  with the  two other cell  lines. 
This difference was reflected  throughout the entire dose-response curve (10  -9 M to  10  -6 M). 
Qualitatively  similar  results  were obtained  when  phosphorylation  was studied  in  the  intact 
cell.  Peptide mapping of the/~-subunit using tryptic digestion and reverse-phase  high-perform- 
ance  liquid  chromatography  column  separation  indicated  three  sites of  phosphorylation  in 
receptor from  the wild  type and  variant 46,  but only two major  sites of phosphorylation  of 
variant  111. These data suggest that the  insulin-resistant  variant  melanoma  1  l l  possesses a 
specific  defect  in the insulin  receptor which alters  both  its binding and autophosphorylation 
properties, and also suggests a possible  role of receptor phosphorylation  in both the binding 
and the signaling  function  of the insulin  receptor. 
Insulin stimulates phosphorylation of the 95,000-mol-wt (j3) 
subunit of the insulin receptor. This phenomenon, first ob- 
served in hepatoma cells and lymphocytes  (1), has been shown 
to occur in all cell types containing insulin receptors (2-12). 
Insulin  receptor phosphorylation  can  be  demonstrated  in 
intact cells  (1,  2,  6,  7)  and  in  cell-free systems using both 
partially purified receptor (2-11) and highly purified receptor 
preparations (5). In broken cell systems, the insulin receptor 
kinase  is  tyrosine specific,  whereas  in  whole  cells,  insulin 
stimulates phosphorylation at both tyrosine and serine resi- 
dues (2,  3). Evidence has been presented using ATP-affinity 
labeling that  the  protein  kinase  activity that  catalyzes the 
phosphorylation is present in the ~3-subunit of the receptor 
itself (12). 
The role of receptor autophosphorylation in the binding 
and  signaling  function of the  receptor is  not  known.  One 
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receptor  phosphorylation  in  cells  with  altered  insulin  re- 
sponse. Cloudman S91  melanoma cells and its variants are a 
good system for such studies. Pawelek and co-workers have 
shown that insulin inhibits growth of the wild-type melanoma 
cell (13).  Thus, it has been possible to select several variants 
from this cell line with altered insulin response. In this paper, 
we  have  characterized  insulin  binding  and  receptor  phos- 
phorylation in the wild-type Cloudman $91  melanoma (1A) 
and two variants: one (111) in which insulin has no effect on 
growth and one (46) in which insulin has a growth-stimulating 
effect (l 4, 15). We find that receptor from the insulin-resistant 
cell  type 111 shows decreased autophosphorylation and de- 
creased receptor affinity. By peptide mapping, the decreased 
phoshorylation appears to be due to a  loss of one of three 
sites of phoshorylation. These data suggest that receptor phos- 
phorylation plays a  role in role in both the binding and the 
signaling function of the insulin receptor and that the mutant 
11 !  possesses a defect which alters these functions. 
MATERIALS  AND  METHODS 
Materials 
Porcine  insulin  (lot  IJM95AN)  was purchased  from Elanco Products  Co. 
(Indianapolis,  IN); [~2P]orthophosphate, [-y-3~P]ATP, and Triton X-100 were 
purchased from New England Nuclear (Boston, MA). Aprotinin,  phenylmeth- 
ylsulfonyl fluoride), and N-acetyl-o-glucosamine  were obtained  from Sigma 
Chemical Co. (St. Louis, MO); wheat germ agglutinin coupled to agarose was 
from Vector Laboratories,  Inc. (Burlingame, CA); and TPCK-treated  trypsin 
was from Worthington  Biochemical  Corp.  (Freehold,  NJ).  All  reagents for 
NaDodSO4 PAGE were from Bio-Rad Laboratories (Richmond,  CA). 
Biologically active ~2~I-insulin was prepared by the lactoperoxidase method 
and  the  A~4[Tyr]monoiodoinsulin was isolated  by high  performance  liquid 
chromatography  (HPLC) ~, resulting in a specific activity of ~360 #Ci/~g (16). 
Cell Culture 
Melanoma  cells were cultured  in modified  Ham's FI0 medium with  5% 
fetal calf serum in monolayer in plastic dishes in a humidified atmosphere  of 
5% CO2/95% O2 at 37"C (13). Medium was changed every 3rd d and cells were 
split when confluence was reached. EDTA (1 mM) was used for cell detachment. 
Confluent  cells were used for binding  and phosphorylation  experiments.  Be- 
cause insulin inhibits growth of  the wild-type 1A cells (13), the insulin-resistant 
111 and insulin-dependent  46 variants could be selected from cells treated with 
ethylmethamesulfonate  then cultured  in the presence of insulin (10  -7 to  10  -6 
M). The variant colonies were isolated and cloned in medium containing  soft 
agar as previously described (15). The wild-type and variant  cells have main- 
rained their characteristic insulin responses for over 2 hr in culture. 
Type 46 was cultivated in the presence of insulin  10  -8 M. Unless otherwise 
stated, however, insulin was removed  from the medium 24-36  h before cells 
were used for insulin binding or phosphorylation  experiments. 
Determination of Rates of Proliferation 
To determine  rates of proliferation  under various culture conditions,  (2 x 
104) cells were inoculated  in 25-cm  2 Coming tissue culture  flasks (Coming 
Glass Work, Coming, NY) in 4 ml medium,  and medium was changed three 
times per week. Triplicate  cultures were harvested and counted  in a Coulter 
Counter (Coulter Electronics, Inc., Hialeah,  FL) every 2 or 3 d over a 2-wk 
period. Variation within triplicate samples was <_+ 15%. The generation time 
was determined  from the  rate  of division  in  log phase  from the  following 
equation:  generation  time =  [0.69 (H)]/[ln (C2/C0], where H  is the time in 
hours between counting the initial cell number (C~) and the final cell number 
(6"2). Generation  time was determined  using only the linear portion of a growth 
curve. 
Abbreviation  used  in  this paper.  HPLC,  high-performance liquid 
chromatography. 
Receptor Phosphorylation in Intact Cells 
Cells were plated in  10-cm tissue culture dishes. After reaching confluence, 
cells were washed twice with phosphate-free Krebs-Ringer bicarbonate  buffer 
containing  0. 1% BSA and 25 mM HEPES, pH 7.4, and incubated  at 37"C in 
this buffer with 0.125 mCi/ml of [a2P]ortbophosphate in a humidified atmos- 
phere containing 7% CO2. After 120 min, insulin (final concentration  5 ×  l0  -7 
M) was added to half of the flasks and incubation  was continued  for 20 rain at 
37"C. The reaction was stopped by addition  of cold Krebs-Rioger bicarbonate 
buffer containing  l0 mM sodium pyrophosphate,  100 mM NaF, and 4 mM 
EDTA, and the cells were washed with this "stopping buffer." 
The [32p]phosphate-labeled cells were solubilized in 25 mM HEPES buffer 
(pH 7.4) containing  1% Triton  X-100, phenylmethylsulfonyl fluoride (2 raM), 
Aprotinin  (l  TIU/ml), l0 mM sodium pyrophosphate,  100 mM NaF, and 4 
mM EDTA at 4"C for 30 rain. Insoluble material was removed by centrifugation 
at  200,000  g  for 60  min,  and  the  supernatants  were  applied  to  columns 
containing wheat germ agglutinin coupled to agarose. After extensive washing 
with 25 mM HEPES buffer (pH 7.4) containing  0.1% Triton  X-100,  l0 mM 
sodium pyrophosphate,  100 mM NaF, and 4 mM EDTA, the bound material 
was eluted  with buffer supplemented  with 0.3  M N-acetylglucosamine. With 
other cell types, this has been shown to result in a 20-fold purification  and a 
100% recovery of the insulin receptor (17). The eluted fractions were precipi- 
tated with sera from patients which contain autoantibodies  against the insulin 
receptor (B-8, 1:300 dilution) or normal pooled serum as previously described 
(l). Alternatively, a  h 100 dilution  of serum from rabbits containing  receptor 
antibody (kindly provided by Dr. S. Jacobs, Burroughs-Wellcome) was used. 
Immunoprecipitates  were solubilized by boiling for 3 min in a solution  of 
2% NaDodSO4, 0.1  M dithiotlireitol, 0.01% bromophenol blue,  10% glycerol, 
and  l0 mM sodium phosphate  (pH 7.0). Electrophoresis was performed  ac- 
cording to Laemmli (18) in 4% stacking and 7.5% resolving gels. After electro- 
phoresis, the slab gels were stained, dried, and autoradiographed  with Kodak 
X-Omat film (Eastman  Kodak  Co., Rochester,  NY) for 10-14  d.  Molecular 
weights were calculated by using standard proteins (5). 
Phosphorylation of Solubilized Wheat Germ 
Purified Receptor In Vivo 
Preparation  of solubilized receptor  and purification  over wheat germ was 
performed  as described  above  except  that  the cells were grown  in  normal 
medium until extraction of the receptors. NaF, sodium pyrophosphate, EDTA, 
and insulin were omitted  from the solubilization buffer. For phosphorylation 
studies, aliquots of the eluted fractions from the lectin column were incubated 
with or without insulin  at room temperature  for 1 h followed by incubation 
with [7-32P]ATP 50-100 ~M in 100 mM HEPES buffer, pH 7.4, containing  10 
mM MgCI2  and 2 mM MnC12 at 4"C or 22"C for 5-60 min. The phosphorylation 
reaction was stopped at 4"C by addition  of NaF (100 mM), sodium pyrophos- 
phate  (10  mM),  EDTA  (5  mM),  and  ATP (5  mM).  The insulin  receptor 
subunits  were identified by immunoprecipitation  with antibodies against insulin 
receptor followed by NaDOdSO4 PAGE under reducing conditions  and auto- 
radiography as described above. 
Insulin Binding 
I N  T  A  C  T C  E  L  L  S  : 36-48  h hours before an experiment, cells were detached 
in a saline solution containing  EDTA (0.2 mg/ml) and transferred to six-well 
tissue culture dishes with  1.2-1.4 x  l06 cells per well. For the binding experi- 
ments, cell incubations  were carried out in a modified Fl0 medium without 
glucose containing  20 mM HEPES at pH 7.8 and 1% bovine serum albumin 
(buffered medium).  Confluent  monolayer cultures of cells (-2 x  106 cells/35- 
mm plate) were incubated with l ml buffered medium (pH 7.8) containing  1- 
3 x  10-u  M ~2~I-insulin  and various concentrations  of unlabeled insulin for 3 
h at  15"C. At the end of the incubation,  the monolayers  were washed three 
times  with  2  ml  of cold  PBS, solubilized in  l  ml of 0.01% SDS and the 
radioactivity  was  quantitated  in  a  Tracer  1190 autogamma counter  (TM 
Analytic, Elk Grove Village, IL). 
BINDING  TO  SOLUBILIZED  RECEPTOR:  Solubilized and wheat germ- 
purified  receptor  was prepared  as described  above.  Aliquots  of wheat  germ 
eluate containing between 10 and 15 #g protein were incubated with ~25I-insulin 
(-10  -u M) and various concentrations  of unlabeled insulin  overnight at 4"C 
in a medium of 150 mM NaC1 and HEPES 25 mM at pH 7.4. Separation of 
the free and receptor-bound  insulin was then performed by precipitation of  the 
solubilized receptor  with  polyethylene glycol 02.5%  final concentration)  as 
described earlier (19), using human V-globulin (0.1 rag) as carrier protein. The 
protein  pellets were washed once with polyethylene glycol and counted  in a 
Tracer  I 190 autogamma counter. 
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Fixed  and dried  polyacrylamide  gel fragments  containing  the phosphorylated 
receptor  (located  by autoradiography)  were washed  for 12 h at 37"C with 20 ml 
of 10% methanol. The absorbent paper was removed from the gel fragment. 
The gel was dried at 70"C for 60 rain and rehydrated in 2 ml of 50 mM 
NH+HCO3 containing  100 pg of  TPCK-treated  trypsin  (Worthington  Biochem- 
ical Corp.). This mixture was incubated  for 24 h at 37"C, the gel fragment  was 
removed and the supernatant was clarified  by centrifugation  and lyophilized. 
The residue was dissolved in  25-50 pl of 0.1% trifluoroacetic  acid. The 
phosphopeptides  were separated  using  a Waters  HPLC system (Waters Instru- 
ments, Inc., Rochester, MN) equipped with a uBondapak Cm reversed-phase 
column (20). Phosphopeptides  applied  to the column were eluted  at a flow  rate 
of 1 ml/min. The column was washed for 5 rain with 0.05% trifluoroacetic 
acid in water and then the peptides  were eluted with a gradient  of acetonitrile 
also containing  0.05% trifluoroacetic  acid increasing  at a rate of 1% per rain. 
Radioactivity  in 0.5-1.0-ml fractions  eluted from the reversed-phase  column 
was measured in 5 ml of scintillation  mixture. 
RESULTS 
Insulin Effect on Cell Growth 
The  effect  of insulin  on  growth  rates  of the  wild  type 
Cloudman $91  melanoma cells and the two variants is shown 
in Fig.  1. Insulin (-7  x  10 -7 M) inhibited the growth of the 
wild-type cells; the generation time for these cells increased 
from  35  to  86  h  in  the  presence  of insulin.  This  effect of 
insulin  has  been  previously shown  to  be  mediated  via the 
insulin  receptor based  on  dose-response curves  for  insulin 
analogues and the ability of antibody to the insulin receptor 
to mimic this effect (13-15).  By contrast, insulin stimulated 
growth  of the  variant cell line 46;  and  the generation time 
decreased from  103 to 47 h. A  similar but smaller effect was 
also  observed  with  physiological concentrations  of insulin 
(15).  No effect of insulin on generation time was detectable 
in the cell line 111. On this basis, we have referred to variant 
111  as an insulin-resistant cell line. 
Insulin Binding 
Insulin  binding  was  studied  in  the  three  melanoma  cell 
lines both in intact cells and with solubilized receptor partially 
purified by wheat germ affinity chromatography (Fig. 2). At 
tracer concentrations,  12~I-insulin  binding to  the  insulin  re- 
sistant variant line 111 was 30%  lower than that of the wild 
type, whereas binding of insulin to the insulin-stimulated line 
46 was  -25%  higher than  the wild type.  In both  cases, the 
change was due to a change in specific binding with no change 
in  nonspecific binding.  Unlabeled insulin  competed  for la- 
beled-insulin binding with a similar dose dependence, and at 
maximal  insulin  concentrations there was  no  difference of 
binding between  the three cell lines. When  insulin  binding 
was studied in solubilized wheat germ-purified material from 
each  of the  three cell lines, a  similar picture was  observed 
(Fig. 2B), i.e., binding was slightly lower in the extract of 111 
and slightly higher in the extract of 46 than in the wild type 
when  expressed per microgram of protein.  Thus,  there was 
no apparent difference in the yield of receptor after solubili- 
zation and wheat germ purification among the three cell types, 
and  the  differences in  the  binding present in the  three cell 
lines was retained after solubilization and partial purification. 
Analysis of insulin binding for all three cell types yielded 
curvilinear Scatchard plots (Fig. 3).  Quantitative analysis of 
the Scatchard plots were performed using a  negative cooper- 
ative model (21) and an M-lab computer modeling program. 
Using this model, the decrease in binding in the resistant cell 
line  was  due  to  a  decrease  in  affinity with  no  change  in 
receptor  concentration  (84.5  vs.  95  fmol/mg  of  protein). 
Receptor  concentration  was  also  similar in  the  insulin-de- 
pendent cell line 46.  Thus,  all three melanoma lines exhibit 
similar receptor numbers,  but  the  insulin-resistant line I11 
exhibits decreased receptor affinity, and the insulin-dependent 
line 46 exhibits a slightly increased receptor affinity. 
Receptor Phosphorylation in Variant and 
Wild-Type Cells 
In vitro autophosphorylation of the 95,000-M, subunit of 
the insulin receptor was studied after wheat germ purification 
of the receptor. As in other cell lines, when equal amounts of 
the partially purified receptor isolated from each of the cell 
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FIGURE  1  Growth  of  Cloudman  melanoma cell  lines.  Cells were  cultured  and  cell  number was  determined  as described  in 
Materials and Methods. A contains data on the wild-type cell (1A); C is data on the insulin-dependent variant (46}; and B is data 
on the  insulin-resistant variant (11/).  The data in  the solid line are in  the absence of  insulin,  and with  the broken  line  in the 
presence of 7 x  10  -7 M  insulin. 
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by x. 
lines  were incubated  in  vitro with  [3,-32p]ATP, Mn  +÷,  and 
insulin,  and  the  proteins analyzed by immunoprecipitation 
and  NaDodSO4 gel electrophoresis, autophosphorylation of 
the receptor was observed (Fig.  4). In all three cell lines, the 
major phosphorylated protein had a Mr = 95,000, the position 
previously  shown  to  contain  the  #-subunit  of the  insulin 
receptor. Further evidence that this was the B-subunit of the 
receptor  was  the  finding  that  the  protein  was  specifically 
precipitated by antireceptor antibody (Fig.  5,  lanes A,  C, E, 
G, I, K vs. B, D, F, H, J, L) and that the phosphorylation was 
stimulated  by insulin  (Fig.  5,  lanes  C,  G,  K  vs.  A,  E,  I). 
Quantitatively, insulin receptor from the insulin-resistant cell 
line  111  was less  heavily phosphorylated than  the  receptor 
from the two insulin-sensitive cell lines when studied at equal 
protein concentration (Figs.  4  and Fig.  5,  lane G  vs.  C  and 
K). 
Two kinds of evidence indicate that the lower phosphoryl- 
ation of the 95,000-M, band in 111 cells was not caused by a 
less efficient immunoprecipitation of the receptor in this cell 
line.  First, when antibodies to the insulin receptor raised in 
rabbits were used for immunoprecipitation instead of human 
autoantibodies,  a  similar  decrease  in  phosphorylation  was 
seen. Secondly, in experiments in which the partially purified 
receptor was not immunoprecipitated, but subjected directly 
to electrophoresis after phosphorylation, the insulin-depend- 
ent phosphorylation of the 95,000-Mr band was decreased in 
line  111  when compared with the other two cell  lines (data 
not shown). 
As  shown  in  Fig.  3,  when  insulin  was removed  for the 
culture medium 24 h before study, type 46 cells had a similar 
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FIcuRE 3  Scatchard  plot  of insulin binding to  intact  melanoma 
cells. The data are those  in Fig. 2, and the code is the same. The 
Scatchard plots were fit using a negative cooperative  model  (21) 
and an M-lab computer program. 
number of insulin receptors as the wild-type melanoma, and 
under these conditions, this cell line showed the same intensity 
of autophosphorylation as the wild-type cell.  If insulin  was 
not removed from the culture media, type 46 cells exhibited 
~50%  loss  of receptors  due  to  down-regulation  (data  not 
shown)  and  also  a  less  intense  phosphorylation  of the  B- 
subunit than the wild-type 1A  melanoma (Fig.  5, lane C vs. 
RARING ET AL.  Insulin Binding and Receptor Phosphorylation  903 FIGURE  4  Insulin-receptor autophosphorylation in vitro. Insulin re- 
ceptors were partially  purified  from  the  wild-type  melanoma 1A 
and variants  111  and 46 as described in  Materials and  Methods. 
The partially purified receptor (24/~g in 500/~1) was then phospho- 
rylated at 22°C  by incubation for  10 min with  10  -z M  insulin,  10 
p,M [3,-32p]ATP, and  5  mM  Mn  2÷. The reaction was stopped, the 
receptor  was immunoprecipitated,  and the fl-subunit was separated 
by NaDodSO4  PAGE under reducing conditions. The figure shows 
autoradiograms of the gel lanes. 
K). Even after down-regulation, however, receptor phospho- 
rylation in type 46 cells was greater than in variant I 1 I. 
Characterization  of the Autophosphorylation 
Fig.  6  shows the time course of receptor phosphorylation 
in  all  three cell types.  In this in  vitro system,  all  cell types 
exhibited sigmoidal kinetics of phosphorylation with an initial 
lag period and a half time of ~20  min. The decreased phos- 
phorylation of receptor from line 111 was evident at all time 
points studied. The exact significance of the sigmoidal kinetics 
is unknown at present, but may suggest a positive cooperativ- 
ity of the phosphorylation process in the solubilized system 
due to activation of the receptor kinase by the autophospho- 
rylation, as suggested by Rosen et al. (22). 
Quantitation of phosphorylation was performed by densi- 
tometric scanning of gels.  An effect of insulin was detectable 
at 10  -9 M in all three cell types and half-maximal stimulation 
was observed between 10  -9 and 10  -8 M (Fig. 7). This is similar 
to the dose-response in other cell lines and is similar to the 
displacement curves of insulin binding in Fig.  2.  A  decrease 
in the phosphorylation of the receptor in type  111  was ob- 
served  in  six  separate experiments at  all  insulin  concentra- 
tions. At concentrations of insulin which saturate all receptors, 
this decrease  averaged  50%  (Table  I).  In  general,  receptors 
from type 46 cells exhibited slightly higher levels of insulin- 
stimulated  phosphorylation  than  receptor  from  wild  type 
(Table I). 
Phosphopeptide  Analysis 
In an effort to determine if the decreased phosphorylation 
in the  111  insulin-resistant variant was due to a  general  or 
specific modification in this receptor, the sites of phosphoryl- 
ation were analyzed by digesting the phosphorylated receptor 
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FIGURE  5  Autoradiogram showing 
the  incorporation of  32p  from  [-y- 
32p]ATP into  the  /3-subunit  of  the 
insulin  receptor in  a  cell-free sys- 
tem. The insulin receptors were par- 
tially purified from wild-type mela- 
noma  1A  (four  right lanes), variant 
/ 11 (four middle lanes), and variant 
46  (four  left  lanes), and  the  phos- 
phorylation assay was performed as 
described  in  the  Materials  and 
Methods  section.  For  each  lane, 
~20 ~g of receptor protein and 0.1 
mCi [-,/YP]ATP was used. Duplicate 
samples were preincubated with in- 
sulin  (5 x  10  -7 M)  for  1 h at room 
temperature  and  phosphorylation 
was performed for 60  min at 4°C. 
The  receptor was immunoprecipi- 
tated by serum containing antibody 
against the receptor (first and third 
lanes for each cell type) or control- 
pooled serum  (second  and  fourth 
lanes).  The  immunoprecipitates 
were  reduced  with  0.1  M  dithio- 
threitol,  analyzed  in  NaDodSO4- 
polyacrylamide (7.5%), and autora- 
diographed. 50- 
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Time course of incorporation of 32p from [V-32P]ATP into 
the ~-subunit of the insulin receptor in  the cell-free system. The 
insulin receptors were partially purified from wild-type melanoma 
1A cells (Q), type 46 cells (x), and type 111  (O). Receptors from all 
three cell types (-20 u.g) were preincubated with insulin  5 x  10  -7 
M  for  1 h  at  room temperature. The  phosphorylation assay was 
carried out  for the time intervals  shown  in  the  figure at 4°C  as 
described in the Materials and Methods section. The receptor was 
immunoprecipitated with  serum  containing antibody against  the 
receptor. The immunoprecipitates were reduced with 0.1 M  dithi- 
othreitol, analyzed in  NaDodSO4 polyacrylamide (7.5%),  and au- 
toradiographed. Phosphorylation of the  95,000-Mr  (95K  subunit) 
receptor subunit was then determined by scanning  densitometry 
and is expressed in relative values. 
with trypsin and subjecting the resultant phosphopeptides to 
analysis by HPLC on a reversed-phase column. In the wild- 
type 1A  cells,  three phosphopeptides were identified (Fig.  8, 
top),  consistent with  our previous observation that  in  vitro 
there are multiple sites of autophosphorylation in the insulin 
receptor (20).  A  similar pattern was observed in the insulin- 
sensitive variant 46 (Fig.  8, bottom). By contrast, the insulin- 
resistant variant 111 appeared to be lacking a discrete peak at 
position 2,  whereas peaks  1 and  3  were unchanged (Fig.  8, 
center).  Due to the low amount of radioactivity in each peak, 
statistical evaluation was impossible; however, similar HPLC 
elution patterns were observed in two separate experiments. 
Receptor Phosphorvlation  in Intact Cells 
Insulin  receptor phosphorylation was also studied  in  the 
intact cell.  To reduce the background of other phosphopro- 
teins in these experiments, a rabbit serum containing antibod- 
ies to the insulin  receptor was used for precipitation or the 
wheat  germ-purified labeled  material  was  first  precipitated 
with control serum and the supernatant was then precipitated 
with  serum  containing antireceptor antibody.  An  autoradi- 
ogram of such an experiment is shown in  Fig.  9.  Although 
the labeling of the receptor was low in intact cells as compared 
with the in vitro assays, in both the wild-type 1A cell and type 
46 phosphorylation of the/~-subunit of the insulin  receptor 
was detectable after insulin stimulation. By contrast, little or 
no phosphorylation of the 95,000-Mr subunit of the insulin 
receptor could be detected in type 111 cells. 
DISCUSSION 
Although  the  exact  mechanism  of insulin  action  remains 
unknown, insulin has been shown to affect the state of phos- 
phorylation of a variety of cellular proteins and enzymes (23- 
26).  This protein modification has been suggested to play a 
role in  the post receptor transmission of the insulin  signal. 
Recently, we have presented evidence that the insulin receptor 
is a protein kinase, and have proposed that receptor-induced 
phosphorylation may be an early step in the signal transmis- 
sion process (1-5). These findings have been confirmed and 
extended using receptors from a  wide variety of tissues (5- 
12). 
Insulin-receptor phosphorylation occurs at  multiple  sites 
(2). The receptor itself  is tyrosine-specific protein kinase which 
will autophosphorylate, as well as catalyze the incorporation 
of phosphate into the tyrosine residues of artificial substrates 
in in vitro systems (5, 22,  27).  In the intact cell, there is also 
phosphorylation of the  /3-subunit  of the  receptor on  serine 
and threonine residues (2) suggesting that in vivo the receptor 
kinase changes in specificity or, more likely, that other (serine) 
kinases which are not part of the receptor may act upon the 
receptor  in  an  insulin-sensitive  way.  The  function  of the 
receptor kinase and autophosphorylation is unclear. 
In the present study, we have shown that an insulin-resistant 
melanoma  cell  line  possesses  an  altered  insulin  receptor, 
which  is  defective  both  in  its  affinity  for  insulin  and  its 
autophosphorylation properties. In the cell-free system, phos- 
phorylation of partially purified receptor from insulin-resist- 
ant melanoma cells is -50% lower than the phosphorylation 
of receptor from the  insulin-sensitive cell lines at  maximal 
insulin concentration. This difference cannot be explained by 
differences in  recovery, differences in  immunoprecipitation 
or the different binding characteristics of the  receptor from 
this cell  line. Although insulin-receptor affinity is decreased 
by  -30%,  decreased  binding  is  seen  only  at  low  insulin 
concentrations; at saturating insulin concentrations the num- 
ber of occupied receptors per milligram of protein is equal in 
all three cell types. Even at saturating insulin concentrations, 
however, phosphorylation is reduced -50%. 
The view that the  reduced phosphorylation is not caused 
by a  lower receptor number is also supported by two other 
types of experimental evidence. In the experiment shown in 
Fig.  5,  receptors from down-regulated type 46  cells,  which 
show -50% reduction in number were used. Phosphorylation 
of the  insulin  receptor of the  down-regulated  46  cells was 
lower than in the 95,000-Mr band of 1A, but was still higher 
than that of the/3-subunit  of type 111  cells.  Thus,  it seems 
likely that the decreased phosphorylation observed with the 
insulin-resistant  cell  111  is  a  reflection  of a  defect  in  the 
receptor itself. 
Peptide  mapping of the  phosphorylated  receptor reveals 
three sites of autophosphorylation in the wild-type and insu- 
lin-sensitive cells, whereas in the insulin-resistant mutant one 
is missing. This would  suggest  a  defect in the receptor as a 
substrate  for autophosphorylation  rather  than  as  a  kinase. 
This is supported by a preliminary observation that the insulin 
receptor from 111 cells is as active as receptor from the wild 
type in catalyzing phosphorylation of an exogenous substrate 
such as histone (White, M. F., and C. R. Kahn; unpublished 
observation).  Whether  there  is  actually  a  modification  in 
sequence of the receptor or in  some other factor that alters 
accessibility of site  2  remains  to  be  determined.  It  is  also 
possible that there is microheterogeneity of receptors, and that 
the lack of site 2 reflects a loss of a particular receptor form. 
Recent studies with epidermal growth  factor (EGF) (28- 
30), platelet-derived growth factor (PDGF) (31, 32) and RNA- 
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FIGURE 7  (left)  Autoradiogram showing the dose response of the insulin effect on incorporation of 32p from [3,-32P]ATP  into the 
~-subunit of the insulin receptor in a cell free system. Insulin receptors were partially purified from wild-type melanoma 1A cells 
(four  left lanes), from  cell type  111  (four  middle lanes), and from  cell type 46  (four  right  lanes). Receptors  (~20 ~tg) were 
preincubated for  1  h  at  room  temperature with  insulin  in  the  concentrations indicated  for  each  lane  in  the  figure.  The 
phosphorylation assay was performed as described in Materials and Methods with ~15-20 ~.g protein and 0.1  mCi  [~'-32P]ATP 
per lane at  4°C for 60 min.  Immunoprecipitation was  performed with antireceptor antibody containing serum  (1:300). The 
immunoprecipitates were reduced with 0.1  M dithiothreitol and analyzed in NaDodSO4-7.5% PAGE. (right). Dose response of 
insulin action on phosphorylation of the insulin receptor 95,000-M, subunit from wild-type IA (@), type 111 (O), and type 46 (x) 
as determined by densitometry scanning in arbitrary  units. 
TABLE  I 
Comparison of Binding and Autophosphorylation 
Characteristics in the Three Melanoma Cell Lines 
Tracer  Receptor  Receptor  Receptor phos- 
Cell line  binding  affinity  capacity  phorylation 
%  %  %  % 
1A  100  100  100  100 
111  63  79  90  49 ±  7 
46  125  156  84  137 ±  18 
The  binding values are derived from  the data shown  in  Figs. 2  and  3 and 
represent the mean of three experiments. The phosphorylation data are the 
mean of seven in vitro experiments using four separate  receptor preparations. 
All data were expressed as the percent of control  observed in the parental 
cell  line {1A) which was taken as  100%.  The values of phosphorylation are 
expressed  as the mean _  SEM. 
tumor viruses  (33-38) suggest that phosphorylation of pro- 
teins  on  tyrosine  is  associated  with  the  regulation  of cell 
proliferation.  Both  EGF  and  PDGF  stimulate  tyrosine-di- 
rected phosphorylation of  their own plasma membrane recep- 
tors.  Both growth factors have also been shown to stimulate 
the phosphorylation of exogenous substrates  via their recep- 
tor-associated kinases. In the case of EGF, a series of mutants 
of the A431  cells in  which the effect  of EGF on growth is 
altered  have  been  studied  to  determine  if there  were  also 
altered  hormone effect  on phosphorylation of the  receptor 
(39).  Unlike  our  study,  however,  all  of the  variants  that 
showed decreased  phosphorylation also  exhibited  a  compa- 
rable decrease  in receptor number. 
Insulin has been shown to be a growth-regulating hormone 
in  a  number  of cell  types  (40-43).  The  observation  that 
insulin,  like EGF and PDGF, acts on tyrosine phosphoryla- 
tion is consistent with the concept that tyrosine-specific  ki- 
nases  may be  important  in  regulation of cell  growth.  The 
coincidence of a  defect in insulin-receptor phosphorylation 
with a loss of the effect of insulin on growth in the 111 variant 
further supports this concept. 
Another result  of the present study is the finding that the 
reduced receptor phosphorylation present in  111 cells is as- 
sociated with a  reduced receptor affinity.  Whether this is a 
result of the same modification of the receptor that results in 
altered  phosphorylation activity is not clear.  Certainly,  it is 
also  possible  that  autophosphorylation may play a  role  in 
modulation of the binding activity of the  receptor affinity. 
The data in the melanoma cells would suggest that receptors 
in a high autophosphorylation state also possess a high affinity 
for hormone. This hypothesis is also supported indirectly from 
studies  in adipocytes and hepatocytes (43-46). In these cells, 
the rate of insulin dissociation decreases within seconds after 
insulin  is bound to the cell. This rapid change appears to be 
independent of internalization and results  from a change in 
the receptor from a low to a high affinity  state.  This change 
of affinity does not occur in ATP-depleted cells (46), and it is 
possible that insulin-induced autophosphorylation is the un- 
derlying process of this insulin-induced change from a low to 
a high affinity state of the receptor. 
Another point worth noting is the difference  between the 
in vitro and in  vivo studies.  The phosphorylation defect  of 
the receptor of type 111  can be clearly demonstrated in the 
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FIGURE 8  Trypsin digestion of the/~-subunit  of the insulin receptor 
obtained from three melanoma cell lines. Partially purified insulin 
receptor (24  #g)  was  phosphorylated at  22"C  during a  10-rain 
interval in a mixture (500 ul) containing 100 nM insulin,  10 #M [3,- 
3zP]ATP, and 5 mM Mn  2+. The reaction was stopped, the receptor 
was  immunoprecipitated, and  the  /~-subunit  was  separated  by 
NaDodSO4 PAGE under reducing conditions. The polyacrylamide 
gel fragments containing the ~-subunit were identified by autora- 
diography, excised, and incubated with trypsin for 24 h as described 
in  Materials  and  Methods.  The phosphopeptides obtained from 
each cell type (IA top; 111 middle; 46 bottom) were separated by 
reversed-phase HPLC on a ~Bondapak  Cla column. The experiment 
shown is one of two, both of which showed a decrease of material 
in the peak 2 region. 
in vitro system, whereas its demonstration in the intact cell 
was more difficult to interpret because of the low intensity of 
the 95,000-M,  band. In two experiments with the intact 111 
cells in which a double immunoprecipitation was performed 
to reduce background, there was no detectable insulin effect 
consistent with an abnormality of receptor phosphorylation 
in this cell line. Phosphorylation of the receptor in intact cells 
involves both a tyrosine kinase (the receptor) and an unknown 
serine  kinase (2).  The  latter  is  not  present  on  the  in  vitro 
system  (3)  and,  therefore,  a  defect  in  the  intrinsic  insulin 
receptor kinase could be more or less apparent in the intact 
cell  than  in  the partially purified  system depending  on the 
activity of this serine kinase. 
In summary, the insulin-resistant melanoma 111 contains 
a  mutant insulin receptor, which is altered in both its auto- 
phosphorylation and insulin binding activity. The data of this 
study  support the concept that  receptor phosphorylation is 
FIGURE 9  Autoradiogram showing the 32p labeling  of the #-subunit 
of the insulin  receptor in  intact melanoma cells.  Melanoma cells 
labeled with  [32P]orthophosphate  for 7  h  and  half of the dishes 
were incubated with 5 x  10  -7 M insulin for another 3 min at 37°C. 
Cells were solubilized and the insulin receptor were partially puri- 
fied on wheat germ  agglutinin-agarose.  Immunoprecipitation was 
performed  first  with  pooled  human  control  serum  followed by 
immunoprecipitation of  the  supernatant  with  serum  containing 
antireceptor antibody in a 1:300 final dilution. The immunoprecip- 
itates  were  reduced  with  0.1  M  dithiothreitol and  analyzed in 
NaDodSO4 PAGE. Autoradiography was performed for 10 d. The 
two left lanes show the data of the melanoma wild-type  1A, the 
two middle lanes show the data of the insulin-resistant variant I I 1, 
and the two right lanes show the insulin-stimulated variant 46. The 
second lane of each panel shows the effect of insulin. 
involved in insulin signal transmission. Furthermore, the data 
suggest the possibility that receptor phosphorylation also may 
influence the binding affinity of the insulin receptor. 
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